Collegium Pharmaceutical, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €629.48M +10.9% €190.74M +27.0% 30.3% +0.038 pp N/A N/A
    (estimated) €567.44M -7.0% €150.20M -28.9% 26.5% -0.082 pp N/A N/A
    (estimated) €610.08M -8.2% €211.32M -16.0% 34.6% -0.032 pp N/A N/A
    (estimated) €664.40M +3.4% €251.57M +7.9% 37.9% +0.016 pp €306.30M +13.6% 46.1% +0.041 pp
    (estimated) €642.83M +18.9% €233.17M +293.7% 36.3% +0.25 pp €269.74M +52.5% 42.0% +0.092 pp
    €540.58M +11.4% €59.23M +43.7% 11.0% +0.025 pp €176.90M -24.9% 32.7% -0.16 pp
    €485.20M +22.2% €41.23M -292.6% 8.5% +0.14 pp €235.60M +118.7% 48.6% +0.21 pp
    €397.17M +67.6% -€21.40M -135.0% -5.4% -0.31 pp €107.74M +19.3% 27.1% -0.11 pp
    €237.02M -10.7% €61.23M +167.3% 25.8% +0.17 pp €90.32M -77.4% 38.1% -1.1 pp
    €265.40M +4.5% €22.90M -428.3% 8.6% +0.11 pp €400.41M +1,266.7% 150.9% +1.4 pp
    €254.00M +5.8% -€6.98M -79.2% -2.7% +0.11 pp €29.30M -82.3% 11.5% -0.58 pp
    €240.06M +884.7% -€33.50M -47.7% -14.0% +2.5 pp €165.86M -393.4% 69.1% +3.0 pp
    €24.38M +1,564.3% -€64.09M -20.5% -262.9% +52 pp -€56.53M -8.4% -231.9% +40 pp
    €1.46M +∞% -€80.62M +245.5% -5,504.1% -55 pp -€61.70M +239.9% -4,212.5% -42 pp
    €0.00 +NaN% -€23.33M +52.1% N/A -€18.15M +18.2% N/A
    €0.00 +NaN% -€15.34M +10.6% N/A -€15.36M +9.9% N/A
    €0.00 -€13.87M N/A -€13.97M N/A

    Notifications